A detailed history of Lgl Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lgl Partners, LLC holds 2,005 shares of LLY stock, worth $1.59 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
2,005
Previous 1,985 1.01%
Holding current value
$1.59 Million
Previous $1.8 Million 1.17%
% of portfolio
0.28%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $15,442 - $19,200
20 Added 1.01%
2,005 $1.78 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $3,624 - $4,545
5 Added 0.25%
1,985 $1.8 Million
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $164,039 - $219,461
-277 Reduced 12.27%
1,980 $1.54 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $251,226 - $295,712
2,257 New
2,257 $293,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lgl Partners, LLC Portfolio

Follow Lgl Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgl Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgl Partners, LLC with notifications on news.